Skip to Content
Merck
CN

CR0003L200

Mobius® 3 L Bioreactor

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

eCl@ss:
32031690
UNSPSC Code:
23151806
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

General description

The Mobius® 3 L bioreactor is a single-use,stirred tank bioreactor for bench-scale cell culture in fed-batch or perfusionmode. Its rigid design includes asemi-hemispherical shaped polycarbonate vessel, a multi-port high-densitypolyethylene (HDPE) headplate, a scoping marine impeller, both open pipe andsintered spargers, weldable C-Flex® tubing, and all necessary gas inlet andoutlet filters. It contains ports below the minimum working volume levelincluding one luer actuated sample port, one liquid inlet/outlet port, twoliquid addition lines, sparging lines and a harvest line. All gas and liquidaddition ports located below the minimum working volume incorporate checkvalves to ensure uni-directional flow of gas or liquid. The Mobius® 3 LBioreactor is pre-assembled, gamma irradiated and shipped ready to use.

Legal Information

C-Flex is a registered trademark of Saint-Gobain Performance Plastics Corp.
MOBIUS is a registered trademark of Merck KGaA, Darmstadt, Germany




Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Articles

High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.

How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.

Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.

Related Content

生物制药开发商需要高效、高产的上游工艺来提供优质的单克隆抗体(mAb)和其他类型重组蛋白。工艺强化可确保生产策略适应未来发展需求、降低成本并提升设施灵活性。

生物制药开发商需要高效、高产的上游工艺来提供优质的单克隆抗体(mAb)和其他类型重组蛋白。工艺强化可确保生产策略适应未来发展需求、降低成本并提升设施灵活性。

了解有关 mAB 生物反应器生产以及该步骤所需产品的更多信息。

View All Related Content